Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in LTRN held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | BIOS Capital Management, LP | 864K | $1.2M | -14.4% | 6.775% | 2.24% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 332K | $455K | — | 2.603% | 0.00% |
| 3 | CM Management, LLC | 250K | $343K | +11.1% | 1.959% | 0.29% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 116K | $159K | +5.1% | 0.909% | 0.00% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 112K | $153K | +15.4% | 0.875% | 0.00% |
| 6 | Westside Investment Management, Inc. | 50K | $69K | +39.4% | 0.392% | 0.01% |
| 7 | Voss Capital, LLC | 50K | $69K | 0.0% | 0.392% | 0.00% |
| 8 | VANGUARD FIDUCIARY TRUST CO | 50K | $68K | — | 0.389% | 0.00% |
| 9 | BlackRock, Inc. | 45K | $62K | +2.3% | 0.355% | 0.00% |
| 10 | DIMENSIONAL FUND ADVISORS LP | 38K | $52K | -2.7% | 0.298% | 0.00% |
| 11 | HORIZON KINETICS ASSET MANAGEMENT LLC | 26K | $36K | -4.4% | 0.207% | 0.00% |
| 12 | DAVENPORT & Co LLC | 24K | $33K | 0.0% | 0.187% | 0.00% |
| 13 | STATE STREET CORP | 24K | $32K | 0.0% | 0.185% | 0.00% |
| 14 | Bank of New York Mellon Corp | 21K | $29K | -19.6% | 0.167% | 0.00% |
| 15 | NORTHERN TRUST CORP | 16K | $21K | 0.0% | 0.122% | 0.00% |
| 16 | Focus Partners Wealth | 15K | $21K | -3.4% | 0.121% | 0.00% |
| 17 | Cetera Investment Advisers | 12K | $17K | 0.0% | 0.096% | 0.00% |
| 18 | UBS Group AG | 10K | $14K | -5.2% | 0.079% | 0.00% |
| 19 | Tower Research Capital LLC (TRC) | 4K | $5K | +324.4% | 0.028% | 0.00% |
| 20 | Vanguard Global Advisers, LLC | 2K | $3K | — | 0.018% | 0.00% |
| 21 | SBI Securities Co., Ltd. | 2K | $3K | +0.1% | 0.017% | 0.00% |
| 22 | CURIO WEALTH, LLC | 2K | $3K | 0.0% | 0.016% | 0.00% |
| 23 | WELLS FARGO & COMPANY/MN | 1K | $2K | 0.0% | 0.012% | 0.00% |
| 24 | MORGAN STANLEY | 601 | $823 | 0.0% | 0.005% | 0.00% |
| 25 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 500 | $685 | +16566.7% | 0.004% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in LTRN — a direct measure of their conviction.
Filings activity in LTRN during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new LTRN position in Q1 2026
Institutions that fully closed their LTRN position in Q1 2026
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 31 | 6.1% | 5.73% | 8.10 pp | $3M | 59% |
| Q4 2025 | 33 | +14% | 13.83% | 5.84 pp | $7M | 30% |
| Q3 2025 | 29 | 15% | 19.67% | +5.48 pp | $10M | +39% |
| Q2 2025 | 34 | +6.3% | 14.19% | 3.06 pp | $7M | 18% |
| Q1 2025 | 32 | +3.2% | 17.25% | +1.58 pp | $9M | +10% |
| Q4 2024 | 31 | +0.0% | 15.67% | +5.81 pp | $8M | +59% |
| Q3 2024 | 31 | 24% | 9.86% | 2.45 pp | $5M | 20% |
| Q2 2024 | 41 | — | 12.31% | — | $6M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Latest Form 4 transactions by company officers and directors. Insider buys are widely viewed as the highest-conviction signal because executives are risking personal capital.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| May 12, 2026 | Schalop Lee Troy | Buy | 49K | $2.06 | $100K |
| May 12, 2026 | KEYSER D JEFFREY | Buy | 49K | $2.06 | $100K |
Quick answers to the most common questions about buying LTRN stock.
Based on Q1 2026 13F filings, institutional ownership of Lantern Pharma Inc. stands at 5.7%, held across 31 reporting institutions.
BIOS Capital Management, LP is the largest reported institutional holder of LTRN, with approximately 864,435 shares worth $0.00B as of Q1 2026.
Yes — 1 widely-followed marquee investor appear among the top 25 institutional holders of LTRN, including RENAISSANCE TECHNOLOGIES LLC.
Our composite Smart Money Score for LTRN is 33 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
5 institutions opened new positions in LTRN during Q1 2026, while 7 fully exited. 2 added to existing positions and 24 trimmed.
LTRN institutional ownership fell by 8.10 percentage points quarter-over-quarter, with a net change of -2 holders.
The top 10 institutions account for 92.2% of all reported 13F value in LTRN, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Lantern Pharma Inc. (LTRN) Institutional Ownership